Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-03 Option Award(A) |
2021-02-18 6:50 pm |
N/A 2031-02-02 |
Sana Biotechnology Inc. | SANA | AGARWAL SUNIL See Remarks |
76,682 | $0 | 76,682 (Direct) |
View |
| 2021-02-08 Conversion |
2021-02-10 7:22 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | ARCH Venture Fund X L.P. CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner |
65,625,000 | $0 | 11,718,750 (Indirect) |
View |
| 2021-02-08 Conversion |
2021-02-10 7:20 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | ARCH Venture Fund X L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners IX LLC ARCH Venture Partners X LLC 10% Owner |
65,625,000 | $0 | 11,718,750 (Indirect) |
View |
| 2021-02-08 Conversion |
2021-02-10 7:00 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | Bishop Hans Edgar Director |
4,062,500 | $0 | 5,736,250 (Direct) |
View |
| 2021-02-08 Conversion |
2021-02-10 6:59 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | Flagship Ventures Fund V General Partner LLC Flagship V VentureLabs Rx Fund L.P. Flagship Ventures Fund V L.P. Flagship Pioneering Inc. Flagship Pioneering Fund VI General Partner LLC Flagship Pioneering Fund VI L.P. Flagship VentureLabs V Manager LLC Flagship VentureLabs V LLC AFEYAN NOUBAR 10% Owner |
34,239,018 | $0 | 11,585,199 (Indirect) |
View |
| 2021-02-08 Conversion |
2021-02-10 6:54 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director |
65,625,000 | $0 | 11,718,750 (Indirect) |
View |
| 2021-02-08 Conversion |
2021-02-10 6:53 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | Harr Steve President & CEO |
4,062,500 | $0 | 8,856,250 (Direct) |
View |
| 2021-02-08 Conversion |
2021-02-10 6:52 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | von Maltzahn Geoffrey Director |
1,830,610 | $0 | 1,830,610 (Direct) |
View |
| 2021-02-08 Conversion |
2021-02-10 6:40 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | MacDonald James J. See Remarks |
101,562 | $0 | 686,562 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 5:27 pm |
N/A 2031-02-02 |
Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 5:22 pm |
N/A 2031-02-02 |
Sana Biotechnology Inc. | SANA | von Maltzahn Geoffrey Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 5:21 pm |
N/A 2031-02-02 |
Sana Biotechnology Inc. | SANA | Bishop Hans Edgar Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 5:20 pm |
N/A 2031-02-02 |
Sana Biotechnology Inc. | SANA | AGARWAL SUNIL See Remarks |
48,000 | $0 | 48,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 5:18 pm |
N/A 2031-02-02 |
Sana Biotechnology Inc. | SANA | Bilenker Joshua H. Director |
7,000 | $0 | 7,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 5:16 pm |
N/A 2031-02-02 |
Sana Biotechnology Inc. | SANA | Cole Douglas G. Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 5:16 pm |
N/A 2031-02-02 |
Sana Biotechnology Inc. | SANA | Wilderotter Mary Agnes Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 5:15 pm |
N/A 2031-02-02 |
Sana Biotechnology Inc. | SANA | Seitz Michelle Director |
7,000 | $0 | 7,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 5:15 pm |
N/A 2031-02-02 |
Sana Biotechnology Inc. | SANA | REICIN ALISE Director |
7,000 | $0 | 7,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 5:14 pm |
N/A 2031-02-02 |
Sana Biotechnology Inc. | SANA | Yang Patrick Y Director |
14,000 | $0 | 14,000 (Direct) |
View |
Ownership |
2021-02-03 9:47 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | AGARWAL SUNIL See Remarks |
0 | $0 | 1,810,000 (Direct) |
View |
Ownership |
2021-02-03 9:30 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | ARCH Venture Fund X L.P. CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 44,042,500 (Indirect) |
View |
Ownership |
2021-02-03 9:30 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director |
0 | $0 | 44,042,500 (Indirect) |
View |
Ownership |
2021-02-03 9:27 pm |
N/A 2030-05-09 |
Sana Biotechnology Inc. | SANA | Wilderotter Mary Agnes Director |
0 | $0 | 93,750 (Direct) |
View |
Ownership |
2021-02-03 9:27 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | ARCH Venture Fund X L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners IX LLC ARCH Venture Partners X LLC 10% Owner |
0 | $0 | 44,042,500 (Indirect) |
View |
Ownership |
2021-02-03 9:23 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | Hordo Christian SVP, Chief Business Officer |
0 | $0 | 1,312,500 (Direct) |
View |
Ownership |
2021-02-03 9:12 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | von Maltzahn Geoffrey Director |
0 | $0 | 1,830,610 (Direct) |
View |
Ownership |
2021-02-03 9:11 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | Yang Patrick Y Director |
0 | $0 | 146,250 (Direct) |
View |
Ownership |
2021-02-03 9:10 pm |
N/A 2030-11-29 |
Sana Biotechnology Inc. | SANA | Seitz Michelle Director |
0 | $0 | 93,750 (Direct) |
View |
Ownership |
2021-02-03 9:09 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | MacDonald James J. See Remarks |
0 | $0 | 967,812 (Direct) |
View |
Ownership |
2021-02-03 9:09 pm |
N/A 2030-12-07 |
Sana Biotechnology Inc. | SANA | REICIN ALISE Director |
0 | $0 | 93,750 (Direct) |
View |
Ownership |
2021-02-03 9:07 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | Mulligan Richard Head of SanaX |
0 | $0 | 3,310,621 (Direct) |
View |
Ownership |
2021-02-03 9:06 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | Harr Steve President & CEO |
0 | $0 | 10,564,973 (Direct) |
View |
Ownership |
2021-02-03 8:43 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | Flagship Ventures Fund V General Partner LLC Flagship V VentureLabs Rx Fund L.P. Flagship Ventures Fund V L.P. Flagship Pioneering Inc. Flagship Pioneering Fund VI General Partner LLC Flagship Pioneering Fund VI L.P. Flagship VentureLabs V Manager LLC Flagship VentureLabs V LLC AFEYAN NOUBAR 10% Owner |
0 | $0 | 34,239,018 (Indirect) |
View |
Ownership |
2021-02-03 8:10 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | Bishop Hans Edgar Director |
0 | $0 | 5,736,250 (Direct) |
View |
Ownership |
2021-02-03 8:09 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | Hardy Nathan SVP, Chief Financial Officer |
0 | $0 | 792,500 (Direct) |
View |
Ownership |
2021-02-03 7:59 pm |
N/A 2030-11-29 |
Sana Biotechnology Inc. | SANA | Bilenker Joshua H. Director |
0 | $0 | 93,750 (Direct) |
View |